Lactoferrin (122), diacerein (36), and resveratrol (37) have been shown to reduce the progression of experimental myopia in animals by inhibiting the expression of inflammatory cytokines related to the MAPK or NF-κB signaling pathways in the retina. The gene discussed is NFKB1; the disease is myopia.